CFTR and cystic fibrosis: In the search of novel and non-invasive biomarkers, which should be predictive of the therapeutic response in CF patients, we recently demonstrated [22] that human peripheral blood monocytes (MNCs) isolated from CF patients treated with ivacaftor could represent an important tool for the analysis of CFTR-dependent chloride efflux rescue and to evaluate the therapeutic response in CF patients.